Sort
30,917 grants matching “tumor microenvironment”
Project 2
$446,235Dan Theodorescu · Cedars-Sinai Medical Center · U54 · FY2022 · CA
Precision lung cancer therapy design through multiplexed adapter measurement
$446,226Aaron Samuel Meyer · University Of California Los Angeles · U01 · FY2017 · CA
Epigenetically regulated stemness program and stem cell niche as targets in pediatric DIPG
$446,213Stefanie Galban · University Of Michigan At Ann Arbor · R01 · FY2025 · NS
Preventing follicular lymphoma progression and transformation through precision therapy
$446,170Wendy Beguelin · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Targeting HSP70 for MelanomaTherapy
$446,169Maureen E Murphy · Wistar Institute · P01 · FY2023 · CA
PAI-1-mediated early-onset endometrial cancer
$446,169Tim H.-M. Huang · University Of Texas Hlth Science Center · R01 · FY2021 · CA
Gut Microbiome, Antibiotic Use & Colon Cancer Recurrence
$446,142Veronika Fedirko · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Nanoscale Coordination Polymers of Cyclic-di-nucleotides and Peptide Antigens for Effective Therapy of Metastatic Colorectal Cancer
$446,134Ralph R Weichselbaum · University Of Chicago · R01 · FY2023 · CA
CAREER: Photoacoustic-Brillouin microscopy for multimodal mechanical imaging of tumor growth
$446,127Jitao Zhang · Wayne State University · · FY2024 · ENG
Regulation of Nutrient Stress-Induced Macropinocytosis in Pancreatic Ductal Adenocarcinoma
$446,063Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · CA
Nongenomic Coregulators of RXRalpha
$446,063Xiao-Kun Zhang · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · CA
Regulation of Nutrient Stress-Induced Macropinocytosis in Pancreatic Ductal Adenocarcinoma
$446,063Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2016 · CA
Regulation of Nutrient Stress-Induced Macropinocytosis in Pancreatic Ductal Adenocarcinoma
$446,063Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · CA
KRAS inhibitors prime cancer cells for macrophage-mediated destruction
$446,063Kipp A Weiskopf · Whitehead Institute For Biomedical Res · R01 · FY2025 · CA
KRAS inhibitors prime cancer cells for macrophage-mediated destruction
$446,063Kipp A Weiskopf · Whitehead Institute For Biomedical Res · R01 · FY2023 · CA
Framing Therapeutic Opportunities in Tumor-Activated Gametogenic Programs
$446,019Angelique Wright Whitehurst · Ut Southwestern Medical Center · R01 · FY2020 · CA
Targeting autophagy to enhance immune checkpoint inhibition
$445,954Ravi K Amaravadi · Wistar Institute · P50 · FY2022 · CA
Immunometabolic pathways enabled by PARP inhibition in breast cancer
$445,716Jennifer L. Guerriero · Brigham And Women'S Hospital · R37 · FY2024 · CA
Proj 4: Triggers for the Induction of T Cell Dysfunction on T cells in Glioblastoma
$445,712Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2021 · CA
Proj 4: Triggers for the Induction of T Cell Dysfunction on T cells in Glioblastoma
$445,712Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2020 · CA
Personalization and Failure Testing of Dual Switch Gene Drives in Lung Cancer
$445,665Justin Pritchard · Pennsylvania State University, The · U01 · FY2023 · CA
Targeting macrophages in metastatic cancer
$445,546Anthony Rongvaux · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Stromal senescence in lethal prostate cancer: a novel target for prognosis and therapy
$445,544Elizabeth A. Platz · Johns Hopkins University · R01 · FY2021 · CA
Protein Kinase Cz targets in Intestinal Cancer Stem Cells
$445,518Jorge Moscat · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2013 · CA
Protein Kinase Cz targets in Intestinal Cancer Stem Cells
$445,518Jorge Moscat · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · CA